SPL — Starpharma Holdings Share News
0.000.00%
Last trade - 00:00- AU$221.83m
- AU$211.52m
- AU$12.05m
Brief: Starpharma Says Viraleze Shows Antiviral Efficacy In Covid-19 Patients
Brief: Starpharma Holdings Appoints Cheryl Maley As CEO & Managing Director
Australia's Starpharma hits 1-month high on prostate cancer drug results
Brief: Starpharma To Receive A$6.5M From Mundipharma And Vivagel BV Rights
Australia's Starpharma tanks to 14-1/2 year low as therapy development stopped
Brief: Starpharma Holdings Says Astrazeneca Has Made Decision To Discontinue Development Of Azd0466
Brief: Starpharma Holdings Ltd Seeks Trading Halt
Starpharma tanks to over 14-year low after cancer drug trial halted
Brief: Starpharma Holdings Says CEO To Retire In 2024
Brief: Starpharma Says Got Regulatory Approval For Viraleze™, In Malaysia
Brief: Starpharma Says Justin Cahill Commences In Role Of Chief Financial Officer
Brief: Starpharma Holdings Appoints Justin Cahill As CFO
Brief: Starpharma Posts HY Revenue From Continuing Operations A$1.6 Million
Brief: Starpharma Holdings Says Nigel Baade Has Advised Of His Intention To Leave Starpharma As CFO
Brief: Starpharma Holdings Says Viraleze Nasal Spray Registered In Indonesia
Brief: Starpharma Says It Signed Sales & Distribution Agreement For Viraleze In HK, Macau
Australia's Starpharma rises on distribution deal for nasal spray in HK, Macau
Bell Potter re-inititaes coverage on Australia's StarPharma with 'buy'
Brief: Starpharma Posts FY Loss Attributable A$16.2 Million